<DOC>
	<DOC>NCT00542022</DOC>
	<brief_summary>To demonstrate the clinical effectiveness of MK0812 in the treatment of Arthritis.</brief_summary>
	<brief_title>Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Patient has had diagnosis of RA made at least 6 months prior to study start and was greater than 16 years of age when diagnosed Patient has active RA with a minimum level of disease activity including at least 10 swollen joints and 10 tender or painful joints Excepting rheumatoid arthritis, patient is judged to be in otherwise general good health based on medical history, physical examination, and routine laboratory tests Patient is mentally or legally incapacitated, has significant emotional problems at the time of the study, or has a history of psychosis Patient has a history of any clinically significant disease of the cardiovascular, hepatic, neurological, renal, genitourinary, or hematologic systems or uncontrolled blood pressure Female patient is pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>